Spravato Treatment in Tulsa, OK
For adults living with treatment-resistant depression, finding relief can feel like running out of options. Access Solutions Behavioral Health offers Spravato (esketamine) therapy at our Tulsa clinic, providing an FDA-approved treatment for patients who haven’t responded adequately to traditional antidepressants.
What is Spravato?
Spravato is the brand name for esketamine, a prescription nasal spray that the FDA approved in 2019 for adults with treatment-resistant depression. It received additional approval for depressive symptoms in adults with major depressive disorder who are experiencing acute suicidal thoughts or behavior. Spravato is taken alongside an oral antidepressant and is administered only in certified medical settings under healthcare provider supervision.
Unlike standard antidepressants that can take weeks to produce noticeable effects, Spravato can begin reducing depressive symptoms within hours to days for some patients. That faster onset makes it a meaningful option during severe or acute episodes, when waiting weeks for traditional medications to take effect isn’t realistic.
How Does Spravato Work?
Most traditional antidepressants target serotonin, norepinephrine, or dopamine systems in the brain. Spravato works through a different mechanism — it acts on NMDA receptors, which are part of the glutamate signaling system, and is believed to support the regrowth of neural connections affected by chronic depression.
This different mechanism is part of why Spravato can help patients who haven’t responded to other treatments. When the standard pharmacological pathways aren’t producing results, targeting a different system entirely can open new ground.
Spravato Treatment Protocol
Spravato is administered on a structured schedule that begins with frequent sessions and tapers as patients respond. The induction phase covers the first four weeks and involves twice-weekly sessions. From Weeks 5 through 8, patients typically move to once-weekly treatments. Beginning at Week 9, sessions occur once weekly or once every two weeks based on each patient’s response, with long-term maintenance determined collaboratively between the patient and the psychiatric team.
Spravato Benefits
For patients who have cycled through multiple medications without success, Spravato offers several distinct advantages:
- Rapid relief: Many patients notice improvement in depressive symptoms within hours to days rather than the weeks typical of oral antidepressants.
- An option for treatment-resistant depression: Spravato was developed specifically for patients who haven’t responded adequately to other antidepressants.
- Supervised administration: Every dose is given and monitored in a certified clinical setting to support patient safety.
- Part of a complete plan: Spravato is used alongside an oral antidepressant and therapy, complementing rather than replacing ongoing care.
These benefits are most meaningful when Spravato is matched to the right patient, which is why a thorough psychiatric evaluation always comes first.
Long-Term Benefits
For patients who respond well, Spravato is often part of a longer-term mental health strategy rather than a one-time intervention. Maintenance treatments may continue at a tapered frequency for months, with the duration tailored to individual response and clinical judgment. Throughout treatment, our team continues to monitor progress, adjust the oral antidepressant component as needed, and connect Spravato outcomes with the broader care plan.
Why Choose Access Solutions Behavioral Health for Spravato?
Spravato works best when it’s integrated into a comprehensive mental health care plan rather than delivered in isolation. Several aspects of our clinic make that integration possible.
Coordinated Care Under One Roof
The Spravato clinic operates inside our existing behavioral health practice, so the psychiatric team managing your medications and evaluating your progress also oversees your Spravato sessions. That continuity matters when patients are navigating complex, treatment-resistant conditions.
Experienced Psychiatric Team
Our behavioral health providers have experience treating adults with major depressive disorder, including patients who have tried multiple medications without finding adequate relief.
Comfortable, Supervised Setting
Treatment sessions take place in a quiet, monitored space designed for patient comfort during the two-hour observation period, with staff trained specifically in Spravato administration.
Insurance Navigation
Spravato requires prior authorization with most insurance carriers, and our administrative team works directly with patients and their insurers to coordinate coverage.
Who May Benefit from Spravato?
Spravato is FDA-approved for two specific groups of adults.
The first is patients with treatment-resistant depression, generally defined as major depressive disorder in adults who haven’t responded adequately to at least two different oral antidepressants taken at appropriate doses and durations. For these patients, Spravato is prescribed in combination with a newly initiated oral antidepressant.
The second is adults with major depressive disorder who are experiencing depressive symptoms with acute suicidal ideation or behavior. In this group, Spravato is used as part of short-term treatment to help reduce symptoms, though it does not replace comprehensive psychiatric care or hospitalization when clinically indicated.
What to Expect During Spravato Treatment
Spravato treatment looks different from picking up a prescription at the pharmacy. Because of the medication’s effects and the FDA’s REMS (Risk Evaluation and Mitigation Strategy) requirements, each step happens under supervision in our certified clinic:
- Initial evaluation: The psychiatric team reviews your history and confirms whether Spravato is an appropriate option.
- In-clinic administration: You self-administer the nasal spray under the observation of trained medical staff.
- Observation period: You remain monitored for at least two hours after each dose while staff track blood pressure and overall response.
- Transportation home: Because Spravato affects driving ability, you arrange a ride and do not drive yourself on treatment days.
- Ongoing progress checks: The team monitors your response throughout the course of treatment and adjusts the plan as needed.
Knowing what each visit involves helps patients plan ahead, particularly when it comes to arranging transportation and setting aside time for the observation period.
Schedule a Consultation at Access Solutions Behavioral Health
If you or a loved one is struggling with depression that hasn’t responded to standard treatments, Spravato may be worth discussing with our team. Contact Access Solutions Behavioral Health today to schedule a consultation and find out whether Spravato is an appropriate option for your situation.
